Anzeige
Mehr »
Login
Dienstag, 26.01.2021 Börsentäglich über 12.000 News von 653 internationalen Medien
Letzte große Gelegenheit bei einer ganz großen Kurswette...
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A115GK ISIN: US45773H2013 Ticker-Symbol: GBMB 
Tradegate
26.01.21
16:12 Uhr
7,850 Euro
-0,150
-1,88 %
1-Jahres-Chart
INOVIO PHARMACEUTICALS INC Chart 1 Jahr
5-Tage-Chart
INOVIO PHARMACEUTICALS INC 5-Tage-Chart
RealtimeGeldBriefZeit
7,8507,95016:18
7,8507,95016:18

Aktuelle News zur INOVIO PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
FrShould Inovio Be On Your Buy List As It Tackles A Coronavirus Vaccine?45
INOVIO PHARMACEUTICALS Aktie jetzt für 0€ handeln
DoWhy Editas Medicine, Inovio, Dyne, and CytomX Stocks Are Falling Today65
DoInovio Falls After $150 Million Share Offering Unveiled30
DoHotStocks USA: +35% bei QUTOUTIAO, -6% bei INOVIO24
DoThe Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping20
DoInovio Pharma secures $150.5M capital raise37
DoInovio Pharma Prices Public Offering Of 17.70 Mln Shares At $8.50/shr984WASHINGTON (dpa-AFX) - Inovio Pharmaceuticals Inc. (INO) said that it has priced an underwritten public offering of 17.70 million shares of its common stock at a public offering price of $8.50...
► Artikel lesen
MiMDLY, KODK, NTN and INO among after-hours movers28
MiINOVIO PHARMACEUTICALS, INC. - 8-K, Current Report13
MiIs Inovio Pharmaceuticals a Buy?37
06.01.INOVIO Announces Positive Efficacy Results For Phase 2 Trial Of VGX-31001.041WASHINGTON (dpa-AFX) - Inovio Pharmaceuticals Inc. (INO) on Wednesday announced positive efficacy results for an open-label Phase 2 trial of VGX-3100 to treat HPV-16 and HPV-18-associated...
► Artikel lesen
06.01.Inovio's lead immunotherapy shows promising action in mid-stage vulvar dysplasia study55
05.01.Inovio plans late-stage COVID-19 vaccine study in second quarter 202175
04.01.INOVIO PHARMACEUTICALS, INC. - 8-K, Current Report19
04.01.UPDATE 3-Inovio expects to begin late-stage COVID-19 vaccine study in second quarter37
04.01.Inovio partners with Advaccine to make and sell COVID-19 vaccine in China7
04.01.Don't Sleep on Inovio Pharmaceuticals as a Serious Vaccine Contender19
04.01.UPDATE 2-Inovio partners with Advaccine to make, sell COVID-19 vaccine in China10
04.01.INOVIO, Advaccine Enter Exclusive COVID-19 DNA Vax Pact1
04.01.Inovio Strikes $100M Coronavirus Vaccine Licensing Deal With China's Advaccine17
Seite:  Weiter >>
316 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
12,14,56